Lopez-Blanco Vivian

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$7.82M

Insider Activity of Lopez-Blanco Vivian

The largest sale of all time was on 2017-02-17 and amounted to 15164 shares of Pediatrix Medical Group, Inc. for $1.06M.

Biography of Lopez-Blanco Vivian

No biography is available at this moment.

2018-06-12SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
13,942
0.015%
$46.46$647,775-17.01%
2017-05-05SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
7,778
0.0085%
$55.82$434,183-4.75%
2017-02-17SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
15,164
0.0164%
$70.01$1.06M-23.01%
2017-01-17SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
10,000
0.0109%
$70.95$709,500-22.72%
2016-05-02SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
9,350
0.0103%
$71.22$665,886-3.27%
2015-07-31SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
10,000
0.0106%
$83.45$834,482-16.06%
2015-02-06SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
8,250
0.0087%
$69.95$577,088+3.33%
2014-10-30SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
8,800
0.0089%
$60.00$528,000+17.16%
2014-02-03SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
9,200
0.0095%
$55.20$507,840+9.73%
2013-04-02SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
3,500
0.007%
$90.00$315,000+14.38%
2012-12-04SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
3,700
0.0074%
$80.00$296,000+14.83%
2012-02-16SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
9,000
0.0187%
$75.00$675,000-3.86%
2011-06-02SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
930
0.002%
$74.56$69,341-3.8%
2011-05-04SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
3,700
0.0077%
$72.00$266,400-4.11%
2010-11-04SalePediatrix Medical Group, Inc.
MD
Chief Financial Officer
3,700
0.0078%
$61.50$227,550+8.92%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.